Back to News
Market Impact: 0.1
Artemis Growth Partners Appoints James Hayward as Advisory Director Amid Institutional Shift in Global Emergent Medicinal Therapeutics
Source: PR Newswire
Management & GovernancePrivate Markets & VentureHealthcare & Biotech
Artemis Growth Partners, an investment firm focused on regulated medical cannabis and emerging medicinal therapeutics, appointed James Hayward as Advisory Director. The announcement is a governance and advisory-team update, with no financial terms, investment figures, or operating targets disclosed in the provided text.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- US aviation sanctions disrupt Iran flights, push travellers overland
- Australia says OpenAI agent hacked Medicare portal
- OpenAI agent hacked into Australian government website, says PM Anthony Albanese
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- OpenAI agents ‘infiltrated Australian government website’
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Alternative Data Due Diligence for Institutional Investors
- Introducing AllMind: A New Data & AI Workspace for Institutional Investors